Axa
AMED

Axa’s Amedisys AMED Stock Holding History

Axa’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,398
Closed -$3.65M – 1062
2023
Q4 		$3.65M Sell
38,398
-1,992
-5% -$186K 0.01% 616
2023
Q3 		$3.77M Sell
40,390
-33,941
-46% -$3.14M 0.01% 591
2023
Q2 		$6.8M Sell
74,331
-751
-1% -$61.6K 0.02% 485
2023
Q1 		$5.52M Buy
75,082
+11,350
+18% +$982K 0.02% 539
2022
Q4 		$5.32M Hold
63,732
– – 0.02% 580
2022
Q3 		$6.17M Sell
63,732
-2,827
-4% -$337K 0.02% 537
2022
Q2 		$7M Sell
66,559
-1,145
-2% -$146K 0.03% 503
2022
Q1 		$11.7M Sell
67,704
-3,396
-5% -$507K 0.03% 452
2021
Q4 		$11.5M Sell
71,100
-52,443
-42% -$8.43M 0.03% 456
2021
Q3 		$18.4M Sell
123,543
-107,294
-46% -$22.3M 0.05% 352
2021
Q2 		$56.5M Buy
230,837
+16,111
+8% +$4.23M 0.16% 156
2021
Q1 		$56.9M Buy
214,726
+28,037
+15% +$7.91M 0.17% 140
2020
Q4 		$54.8M Sell
186,689
-3,433
-2% -$880K 0.17% 139
2020
Q3 		$45M Sell
190,122
-434
-0.2% -$98.7K 0.16% 147
2020
Q2 		$37.8M Buy
190,556
+18,509
+11% +$3.45M 0.15% 159
2020
Q1 		$31.6M Buy
172,047
+96,518
+128% +$17.2M 0.16% 155
2019
Q4 		$12.6M Buy
75,529
+33,498
+80% +$4.98M 0.05% 394
2019
Q3 		$5.51M Buy
42,031
+9,630
+30% +$1.25M 0.02% 623
2019
Q2 		$3.93M Sell
32,401
-67,200
-67% -$7.97M 0.02% 714
2019
Q1 		$12.3M Sell
99,601
-16,000
-14% -$2.01M 0.05% 407
2018
Q4 		$13.5M Buy
115,601
+81,301
+237% +$9.58M 0.06% 360
2018
Q3 		$4.29M Buy
+34,300
New +$3.79M 0.02% 714

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Axa's AMED Position: Q1 2024 in Review

Axa sold out of Amedisys (AMED) in Q1 2024, closing a stake of 38,398 shares — an estimated $3.65M sold.

Axa first reported a position in AMED in Q3 2018 and held it in 22 quarters. The position peaked at $56.9M in Q1 2021. 283 funds tracked by Wall St. Rank hold AMED as of Q1 2024.

  • Axa reported no remaining Amedisys position as of Q1 2024 after selling out during the quarter.
  • Axa sold 38,398 Amedisys shares in Q1 2024, an estimated $3.65M.
  • Axa first reported a position in Amedisys in Q3 2018 and held it in 22 quarters.
  • Axa's Amedisys position peaked at $56.9M in Q1 2021.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.